{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:06:00Z","timestamp":1792497960953,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024063","name":"Brain and Cognition Discovery Foundation","doi-asserted-by":"publisher","award":["BCDF001"],"award-info":[{"award-number":["BCDF001"]}],"id":[{"id":"10.13039\/501100024063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jad.2026.121385","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:54:34Z","timestamp":1770882874000},"page":"121385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression"],"prefix":"10.1016","volume":"403","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5170-0265","authenticated-orcid":false,"given":"Erica S.","family":"Kaczmarek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson B.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3325-5854","authenticated-orcid":false,"given":"Noah","family":"Chisamore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0140-8994","authenticated-orcid":false,"given":"Zoe","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7010-1785","authenticated-orcid":false,"given":"Shakila","family":"Meshkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3597-2571","authenticated-orcid":false,"given":"Marc G.","family":"Blainey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8381-7434","authenticated-orcid":false,"given":"Ryan","family":"Brudner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla M.","family":"Teopiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4773-2191","authenticated-orcid":false,"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.121385_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.brat.2022.104185","article-title":"How well do Cognitive Behavioural Therapy and Behavioural Activation for depression repair anhedonia? A secondary analysis of the COBRA randomized controlled trial","volume":"159","author":"Alsayednasser","year":"2022","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jad.2026.121385_bb0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders, DSM-5-TR. ed","year":"2022"},{"key":"10.1016\/j.jad.2026.121385_bb0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ncl.2025.08.009","article-title":"Placebo effects in the treatment of depression\u2014implications for the psychedelic renaissance","volume":"44","author":"Ansari","year":"2026","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.jad.2026.121385_bb0020","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/070674370705200108","article-title":"Definition, assessment, and staging of treatment\u2014resistant refractory major depression: a review of current concepts and methods","volume":"52","author":"Berlim","year":"2007","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121385_bb0025","doi-asserted-by":"crossref","DOI":"10.1177\/20451253211006508","article-title":"Excess deaths in treatment-resistant depression","volume":"11","author":"Brenner","year":"2021","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.121385_bb0030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pnpbp.2019.01.002","article-title":"Pharmacological interventions targeting anhedonia in patients with major depressive disorder: a systematic review","volume":"92","author":"Cao","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.121385_bb0035","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2026.121385_bb0040","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2026.121385_bb0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s40501-024-00319-8","article-title":"Neurobiology of the antidepressant effects of serotonergic psychedelics: a narrative review","volume":"11","author":"Chisamore","year":"2024","journal-title":"Curr. Treat. Options Psych."},{"key":"10.1016\/j.jad.2026.121385_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112041","article-title":"Anhedonia in depression symptomatology: appetite dysregulation and defective brain reward processing","volume":"372","author":"Coccurello","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.jad.2026.121385_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069637","article-title":"The epidemiological modelling of major depressive disorder: application for the global burden of disease study 2010","volume":"8","author":"Ferrari","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jad.2026.121385_bb0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/15374416.2018.1514611","article-title":"Social anhedonia in children and adolescents with autism spectrum disorder and psychiatry referrals","volume":"49","author":"Gadow","year":"2020","journal-title":"J. Clin. Child Adolesc. Psychol."},{"issue":"1","key":"10.1016\/j.jad.2026.121385_bb0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/0004867413508455","article-title":"Anhedonia in substance use disorders: a systematic review of its nature, course and clinical correlates","volume":"48","author":"Garfield","year":"2014","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121385_bb0070","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1176\/ps.2009.60.11.1439","article-title":"What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression","volume":"60","author":"Gaynes","year":"2009","journal-title":"PS"},{"key":"10.1016\/j.jad.2026.121385_bb0075","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1080\/14737175.2020.1826931","article-title":"The emerging role of psilocybin and MDMA in the treatment of mental illness","volume":"20","author":"Gill","year":"2020","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.jad.2026.121385_bb0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jpsychires.2022.12.024","article-title":"Evaluating Anhedonia as a risk factor in suicidality: a meta-analysis","volume":"158","author":"Gillissie","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2026.121385_bb0085","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2026.121385_bb0090","series-title":"Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach Third Edition","author":"Hayes","year":"2022"},{"key":"10.1016\/j.jad.2026.121385_bb0095","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jad.2026.121385_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.brat.2019.103507","article-title":"Distress and anhedonia as predictors of depression treatment outcome: a secondary analysis of a randomized clinical trial","volume":"125","author":"Khazanov","year":"2020","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jad.2026.121385_bb0105","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jad.2024.03.165","article-title":"Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: a systematic review","volume":"355","author":"Le","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121385_bb0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40263-021-00877-y","article-title":"Molecular mechanisms of psilocybin and implications for the treatment of depression","volume":"36","author":"Ling","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2026.121385_bb0115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamapsychiatry.2022.3860","article-title":"Association of treatment-resistant depression with patient outcomes and health care resource utilization in a population-wide study","volume":"80","author":"Lundberg","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.121385_bb0120","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jad.2021.03.053","article-title":"Validation of the McIntyre And Rosenblat Rapid Response Scale (MARRRS) in adults with treatment-resistant depression receiving intravenous ketamine treatment","volume":"288","author":"McIntyre","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121385_bb0125","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2026.121385_bb0130","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jaac.2012.01.011","article-title":"Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment\u2013resistant depression","volume":"51","author":"McMakin","year":"2012","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry."},{"key":"10.1016\/j.jad.2026.121385_bb0135","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121385_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.788155","article-title":"Therapeutic alliance and rapport modulate responses to psilocybin assisted therapy for depression","volume":"12","author":"Murphy","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jad.2026.121385_bb0145","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/17512433.2021.1933434","article-title":"Blinding and expectancy confounds in psychedelic randomized controlled trials","volume":"14","author":"Muthukumaraswamy","year":"2021","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2026.121385_bb0150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neubiorev.2015.01.019","article-title":"Reward functioning in PTSD: A systematic review exploring the mechanisms underlying anhedonia","volume":"51","author":"Nawijn","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2026.121385_bb0155","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41429-020-0311-8","article-title":"Psilocybin: from ancient magic to modern medicine","volume":"73","author":"Nichols","year":"2020","journal-title":"J. Antibiot."},{"key":"10.1016\/j.jad.2026.121385_bb0160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1744-859X-8-22","article-title":"Anhedonia in schizophrenia and major depression: state or trait?","volume":"8","author":"Pelizza","year":"2009","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2026.121385_bb0165","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1176\/appi.ajp.20220423","article-title":"Toward a better understanding of the mechanisms and pathophysiology of anhedonia: are we ready for translation?","volume":"179","author":"Pizzagalli","year":"2022","journal-title":"AJP"},{"key":"10.1016\/j.jad.2026.121385_bb0170","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","article-title":"Psychedelics and psychedelic-assisted psychotherapy","volume":"177","author":"Reiff","year":"2020","journal-title":"AJP"},{"key":"10.1016\/j.jad.2026.121385_bb0175","series-title":"Anhedonia: A Comprehensive Handbook Volume I: Conceptual Issues And Neurobiological Advances","author":"Ritsner","year":"2014"},{"key":"10.1016\/j.jad.2026.121385_bb0180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.psychres.2015.07.062","article-title":"Development and validation of the Dimensional Anhedonia Rating Scale (DARS) in a community sample and individuals with major depression","volume":"229","author":"Rizvi","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2026.121385_bb0185","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jad.2020.07.083","article-title":"Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: results from the Canadian Rapid Treatment Center of Excellence","volume":"276","author":"Rodrigues","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121385_bb0190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neuropharm.2017.12.041","article-title":"Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression","volume":"142","author":"Roseman","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2026.121385_bb0195","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.medj.2024.01.005","article-title":"Psilocybin-assisted psychotherapy for treatment resistant depression: a randomized clinical trial evaluating repeated doses of psilocybin","volume":"5","author":"Rosenblat","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.jad.2026.121385_bb0200","series-title":"Anhedonia: A Comprehensive Handbook Volume I","first-page":"3","article-title":"The Different Facets of Anhedonia and Their Associations with Different Psychopathologies","author":"Shankman","year":"2014"},{"key":"10.1016\/j.jad.2026.121385_bb0205","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.jad.2026.121385_bb0210","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/02698811221125354","article-title":"Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression","volume":"37","author":"Shukuroglou","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.121385_bb0215","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1192\/bjp.167.1.99","article-title":"A scale for the assessment of hedonic tone the Snaith\u2013Hamilton pleasure scale","volume":"167","author":"Snaith","year":"1995","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2026.121385_bb0220","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.2147\/NDT.S170645","article-title":"Low hedonic tone and attention-deficit hyperactivity disorder: risk factors for treatment resistance in depressed adults","volume":"14","author":"Sternat","year":"2018","journal-title":"NDT"},{"key":"10.1016\/j.jad.2026.121385_bb0225","series-title":"Patterning and Cell Type Specification in the Developing CNS and PNS","first-page":"435","article-title":"The generation of midbrain dopaminergic neurons","author":"Stott","year":"2013"},{"key":"10.1016\/j.jad.2026.121385_bb0230","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00213-017-4754-y","article-title":"Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression","volume":"235","author":"Stroud","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2026.121385_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006598","article-title":"Worth the \u2018EEfRT\u2019? The effort expenditure for rewards task as an objective measure of motivation and anhedonia","volume":"4","author":"Treadway","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.jad.2026.121385_bb0240","article-title":"Psychedelics and other psychoplastogens for treating mental illness","volume":"12","author":"Vargas","year":"2021","journal-title":"Front. Psych."},{"key":"10.1016\/j.jad.2026.121385_bb0245","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.biopsych.2012.10.014","article-title":"Reduced reward learning predicts outcome in major depressive disorder","volume":"73","author":"Vrieze","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.121385_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110289","article-title":"Anhedonia as a central factor in depression: Neural mechanisms revealed from preclinical to clinical evidence","volume":"110","author":"Wang","year":"2021","journal-title":"Progr. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2026.121385_bb0255","series-title":"Anhedonia: Preclinical, Translational, and Clinical Integration, Current Topics in Behavioral Neurosciences","first-page":"111","article-title":"Anhedonia in depression and bipolar disorder","author":"Whitton","year":"2022"},{"key":"10.1016\/j.jad.2026.121385_bb0260","article-title":"Short-term ketamine use in bipolar depression: a review of the evidence for short-term treatment management","volume":"14","author":"Wilkowska","year":"2023","journal-title":"Front. Psych."},{"key":"10.1016\/j.jad.2026.121385_bb0265","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jad.2024.04.086","article-title":"Effects of anhedonia on health-related quality of life and functional outcomes in major depressive disorder: a systematic review and meta-analysis","volume":"356","author":"Wong","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2026.121385_bb0270","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13699","article-title":"The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States","volume":"82","author":"Zhdanava","year":"2021","journal-title":"J. Clin. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726002363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726002363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:07:08Z","timestamp":1786036028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726002363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":54,"alternative-id":["S0165032726002363"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.121385","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.121385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121385"}}